Pharmafile Logo

Lucid Group are shortlisted in three different categories at this year’s PMEA programme

October 16, 2018 |  

- PMLiVE

Lucid’s talent for working together with their clients to create magical programmes is clear to see as they celebrate three of their campaigns making the 2018 PMEA finals, well as making the cut for PMEA Support Agency of Year.

Jan Steele, Lucid Group COO and Co-founder commented, “We are extremely proud of our client partnerships. By continuing to push boundaries and creating industry-leading medical communications, we have, together, been able to transform the lives of those we touch. I am thrilled that their work has been shortlisted at this year’s PMEA.”

The PMEA programme aims to recognise work that delivers clearly identifiable benefits and improved outcomes for patients. The winners will be announced at the awards ceremony on Thursday 22nd November at The Tower – A Guoman Hotel.

More details about the shortlisted campaigns can be found below:

Excellence in Rare Diseases and Orphan Drugs:            

  • Revolutionising management of hidradenitis suppurativa in Europe: Why? What? How?
  • Advancing Science in a Rare Disease – A Cost Effective Clinical Decision Support Programme for Cystinosis.

Excellence in Healthcare Professional Education and Support Programmes:    

  • OptiMiSe: Delivering patient-centric management in MS through clinical behaviour change.

PMEA Support Agency of the Year:

  • LUCID : THE TRANSFORMATION

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education

Lucid Group starts new trend for CME in IBD education

A tailored educational event in IBD